Acrivon Therapeutics Inc
ACRV1.330USD
+0.070+5.56%
Close 08/04, 16:00（ET）Quotes delayed by 15 min
1.330USD+1.330After-hours (ET)
41.70MMarket Cap
LossP/E TTM
Acrivon Therapeutics Inc
1.330
+0.070+5.56%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-14.35%-19.54M
-40.38%-17.36M
-76.66%-17.32M
-52.58%-13.90M
-50.42%-17.08M
-32.20%-12.37M
-50.38%-9.81M
---9.11M
---11.36M
---9.35M
---6.52M
Net income from continuing operations
-19.37%-19.68M
-18.59%-22.83M
-55.13%-22.44M
-35.10%-18.80M
-29.24%-16.49M
-115.61%-19.25M
-57.27%-14.47M
---13.91M
---12.76M
---8.93M
---9.20M
Operating gains losses
38.84%311.00K
103.36%303.00K
88.72%251.00K
76.74%228.00K
79.20%224.00K
19.20%149.00K
14.66%133.00K
--129.00K
--125.00K
--125.00K
--116.00K
Other non-cash items
68.27%-112.00K
-34.57%-654.00K
-77.94%-968.00K
-51.83%-870.00K
62.53%-353.00K
-48.17%-486.00K
-27300.00%-544.00K
---573.00K
---942.00K
---328.00K
--2.00K
Change in working capital
-0.87%-3.84M
-49.22%2.12M
17.42%2.16M
-23.01%1.97M
-786.51%-3.81M
323.09%4.17M
-19.59%1.84M
--2.56M
---430.00K
---1.87M
--2.29M
-Change in prepaid expenses
232.86%466.00K
-377.38%-466.00K
491.89%290.00K
-80.82%273.00K
-76.39%140.00K
106.73%168.00K
-105.10%-74.00K
--1.42M
--593.00K
---2.50M
--1.45M
-Change in other current assets
----
--0.00
---1.18M
----
----
----
----
----
----
----
----
Cash from non-recurring investing activities
Cash from operating activities
-14.35%-19.54M
-40.38%-17.36M
-76.66%-17.32M
-52.58%-13.90M
-50.42%-17.08M
-32.20%-12.37M
-50.38%-9.81M
---9.11M
---11.36M
---9.35M
---6.52M
Investing cash flow
Net cash from continuing investing activities
-92.88%58.00K
-28.15%827.00K
--989.00K
22.32%137.00K
3160.00%815.00K
358.57%1.15M
-100.00%0.00
--112.00K
--25.00K
--251.00K
--426.00K
Capital expenditures
-92.88%58.00K
-28.15%827.00K
--989.00K
22.32%137.00K
3160.00%815.00K
358.57%1.15M
-100.00%0.00
--112.00K
--25.00K
--251.00K
--426.00K
Net cash flow from disposal of fixed assets
-92.88%58.00K
-28.15%827.00K
--989.00K
22.32%137.00K
3160.00%815.00K
358.57%1.15M
-100.00%0.00
--112.00K
--25.00K
--251.00K
--426.00K
Net cash flow from investment products
189.15%19.27M
-29.73%15.24M
1021.37%17.00M
-551.96%-87.91M
-28.73%6.67M
122.87%21.69M
103.39%1.52M
--19.45M
--9.35M
---94.82M
---44.69M
Cash from non-current investing activities
Net cash flow from investing activities
228.44%19.21M
-29.82%14.41M
956.13%16.01M
-555.29%-88.04M
-37.28%5.85M
121.60%20.54M
103.36%1.52M
--19.34M
--9.33M
---95.07M
---45.12M
Financing cash flow
Cash flow from continuous financing activities
-99.42%-343.00K
67.83%-647.00K
-2028.21%-1.50M
32446.17%123.35M
---172.00K
-101.97%-2.01M
155.71%78.00K
--379.00K
--0.00
--101.86M
---140.00K
Net cash flow from common stock issuance/repurchase
----
100.00%0.00
---307.00K
--63.85M
---85.00K
-154.98%-1.03M
----
----
----
--1.88M
----
Net cash flow from preferred stock issuance/repurchase
----
----
----
----
----
----
----
----
----
--0.00
----
Proceeds from stock option exercised by employees
-98.73%1.00K
-100.00%0.00
-100.00%0.00
--11.00K
--79.00K
--318.00K
225.00%78.00K
----
----
--0.00
--24.00K
Proceeds from issuance of warrants
----
--0.00
--0.00
--60.00M
----
----
----
----
----
----
----
Net cash flow from other financing activities
-107.23%-344.00K
50.12%-647.00K
---1.20M
---510.00K
---166.00K
-101.30%-1.30M
100.00%0.00
----
----
--99.98M
---164.00K
Net cash from non-recurrent financing activities
Net cash from financing activities
-99.42%-343.00K
67.83%-647.00K
-2028.21%-1.50M
32446.17%123.35M
---172.00K
-101.97%-2.01M
155.71%78.00K
--379.00K
--0.00
--101.86M
---140.00K
Net cash flow
Beginning cash balance
9.85%40.02M
44.07%43.61M
20.65%46.43M
-10.23%25.02M
21.81%36.43M
-6.77%30.27M
-54.32%38.48M
--27.88M
--29.91M
--32.47M
--84.25M
Current period cash flow changes
94.18%-664.00K
-158.37%-3.59M
65.71%-2.82M
101.82%21.40M
-461.82%-11.40M
340.49%6.16M
84.14%-8.21M
--10.61M
---2.03M
---2.56M
---51.78M
Ending cash balance
57.26%39.35M
9.85%40.02M
44.07%43.61M
20.65%46.43M
-10.23%25.02M
21.81%36.43M
-6.77%30.27M
--38.48M
--27.88M
--29.91M
--32.47M
Free cash flow
-9.47%-19.59M
-34.55%-18.19M
-86.74%-18.31M
-52.21%-14.04M
-57.25%-17.90M
-40.73%-13.52M
-41.15%-9.81M
---9.22M
---11.38M
---9.61M
---6.95M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
